These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Hematologic effects of recombinant murine granulocyte-macrophage colony-stimulating factor on the peripheral blood and bone marrow. Ulich TR; del Castillo J; McNiece I; Watson L; Yin SM; Andresen J Am J Pathol; 1990 Aug; 137(2):369-76. PubMed ID: 1696784 [TBL] [Abstract][Full Text] [Related]
4. Hematopoietic responses in patients with advanced malignancy treated with recombinant human granulocyte-macrophage colony-stimulating factor. Herrmann F; Schulz G; Lindemann A; Meyenburg W; Oster W; Krumwieh D; Mertelsmann R J Clin Oncol; 1989 Feb; 7(2):159-67. PubMed ID: 2644395 [TBL] [Abstract][Full Text] [Related]
5. Effects of recombinant human granulocyte-macrophage colony stimulating factor on hematopoiesis in normal cynomolgus monkeys. Aramaki K; Yanagida M; Kikumori M; Kojima M; Suzuki T; Amano K J Vet Med Sci; 1993 Apr; 55(2):221-5. PubMed ID: 7685638 [TBL] [Abstract][Full Text] [Related]
6. Phase I study of intravenously administered bacterially synthesized granulocyte-macrophage colony-stimulating factor and comparison with subcutaneous administration. Lieschke GJ; Maher D; O'Connor M; Green M; Sheridan W; Rallings M; Bonnem E; Burgess AW; McGrath K; Fox RM Cancer Res; 1990 Feb; 50(3):606-14. PubMed ID: 2404573 [TBL] [Abstract][Full Text] [Related]
7. Yeast-expressed granulocyte-macrophage colony-stimulating factor in cancer patients: a phase ib clinical study. Herrmann F; Schulz G; Lindemann A; Meyenburg W; Oster W; Krumwieh D; Mertelsmann R Behring Inst Mitt; 1988 Aug; (83):107-18. PubMed ID: 2467645 [TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo activity of human recombinant granulocyte-macrophage colony-stimulating factor in dogs. Mayer P; Werner FJ; Lam C; Besemer J Exp Hematol; 1990 Oct; 18(9):1026-33. PubMed ID: 2168838 [TBL] [Abstract][Full Text] [Related]
9. Subcutaneous granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndrome: toxicity, pharmacokinetics, and hematological effects. Thompson JA; Lee DJ; Kidd P; Rubin E; Kaufmann J; Bonnem EM; Fefer A J Clin Oncol; 1989 May; 7(5):629-37. PubMed ID: 2651578 [TBL] [Abstract][Full Text] [Related]
10. The in vivo effects of recombinant human interleukin-3: demonstration of basophil differentiation factor, histamine-producing activity, and priming of GM-CSF-responsive progenitors in nonhuman primates. Mayer P; Valent P; Schmidt G; Liehl E; Bettelheim P Blood; 1989 Aug; 74(2):613-21. PubMed ID: 2665851 [TBL] [Abstract][Full Text] [Related]
11. Differential augmentation of in vivo natural killer cytotoxicity in normal primates with recombinant human interleukin-1 and granulocyte-macrophage colony-stimulating factor. Davis TA; Monroy RL; Skelly RR; Donahue RE; MacVittie TJ Clin Exp Immunol; 1990 Mar; 79(3):436-42. PubMed ID: 2180599 [TBL] [Abstract][Full Text] [Related]
12. Human recombinant derived IL-3 and GM-CSF in hematopoiesis of normal cynomolgus monkeys. Krumwieh D; Weinmann E; Seiler FR Behring Inst Mitt; 1988 Aug; (83):250-7. PubMed ID: 3071338 [TBL] [Abstract][Full Text] [Related]
13. Recombinant human granulocyte colony-stimulating factor. Effects on hematopoiesis in normal and cyclophosphamide-treated primates. Welte K; Bonilla MA; Gillio AP; Boone TC; Potter GK; Gabrilove JL; Moore MA; O'Reilly RJ; Souza LM J Exp Med; 1987 Apr; 165(4):941-8. PubMed ID: 3494094 [TBL] [Abstract][Full Text] [Related]
14. Stimulation of haematopoiesis in primates by continuous infusion of recombinant human GM-CSF. Donahue RE; Wang EA; Stone DK; Kamen R; Wong GG; Sehgal PK; Nathan DG; Clark SC Nature; 1986 Jun 26-Jul 2; 321(6073):872-5. PubMed ID: 3487734 [TBL] [Abstract][Full Text] [Related]
15. Effect of N-methionine-free, bacterially synthesized recombinant human granulocyte-macrophage colony-stimulating factor in a primate model. Akashi K; Taniguchi S; Teshima T; Shibuya T; Okamura T; Harada M; Niho Y Eur J Haematol; 1990 Feb; 44(2):100-5. PubMed ID: 2180740 [TBL] [Abstract][Full Text] [Related]
16. Subcutaneous recombinant granulocyte-macrophage colony-stimulating factor used as a single agent and in an alternating regimen with azidothymidine in leukopenic patients with severe human immunodeficiency virus infection. Pluda JM; Yarchoan R; Smith PD; McAtee N; Shay LE; Oette D; Maha M; Wahl SM; Myers CE; Broder S Blood; 1990 Aug; 76(3):463-72. PubMed ID: 2198957 [TBL] [Abstract][Full Text] [Related]
17. Stimulation of human hematopoietic progenitor cell proliferation and differentiation by recombinant human interleukin 3. Comparison and interactions with recombinant human granulocyte-macrophage and granulocyte colony-stimulating factors. Ottmann OG; Abboud M; Welte K; Souza LM; Pelus LM Exp Hematol; 1989 Feb; 17(2):191-7. PubMed ID: 2463933 [TBL] [Abstract][Full Text] [Related]
18. Stimulation of granulopoiesis by transforming growth factor beta: synergy with granulocyte/macrophage-colony-stimulating factor. Keller JR; Jacobsen SE; Sill KT; Ellingsworth LR; Ruscetti FW Proc Natl Acad Sci U S A; 1991 Aug; 88(16):7190-4. PubMed ID: 1831268 [TBL] [Abstract][Full Text] [Related]
19. Phase I clinical study for recombinant human granulocyte colony-stimulating factor. Asano S; Shirafuji N; Watari K; Matsuda S; Uemura N; Ieki R; Kodo H; Takaku F Behring Inst Mitt; 1988 Aug; (83):222-8. PubMed ID: 2467650 [TBL] [Abstract][Full Text] [Related]
20. Effects of recombinant human granulocyte-macrophage colony-stimulating factor in patients with myelodysplastic syndromes. Vadhan-Raj S; Keating M; LeMaistre A; Hittelman WN; McCredie K; Trujillo JM; Broxmeyer HE; Henney C; Gutterman JU N Engl J Med; 1987 Dec; 317(25):1545-52. PubMed ID: 3500414 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]